75 related articles for article (PubMed ID: 9288787)
21. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p.
Banham AH; Beasley N; Campo E; Fernandez PL; Fidler C; Gatter K; Jones M; Mason DY; Prime JE; Trougouboff P; Wood K; Cordell JL
Cancer Res; 2001 Dec; 61(24):8820-9. PubMed ID: 11751404
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the DNA-binding property of Smad5.
Li W; Chen F; Nagarajan RP; Liu X; Chen Y
Biochem Biophys Res Commun; 2001 Sep; 286(5):1163-9. PubMed ID: 11527422
[TBL] [Abstract][Full Text] [Related]
23. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
Willman CL; Sever CE; Pallavicini MG; Harada H; Tanaka N; Slovak ML; Yamamoto H; Harada K; Meeker TC; List AF
Science; 1993 Feb; 259(5097):968-71. PubMed ID: 8438156
[TBL] [Abstract][Full Text] [Related]
24. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
[TBL] [Abstract][Full Text] [Related]
26. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31.
Horrigan SK; Arbieva ZH; Xie HY; Kravarusic J; Fulton NC; Naik H; Le TT; Westbrook CA
Blood; 2000 Apr; 95(7):2372-7. PubMed ID: 10733509
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers.
Hagiwara K; McMenamin MG; Miura K; Harris CC
Cancer Res; 1999 Sep; 59(17):4165-9. PubMed ID: 10485447
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q.
Gao Q; Horwitz M; Roulston D; Hagos F; Zhao N; Freireich EJ; Golomb HM; Olopade OI
Genes Chromosomes Cancer; 2000 Jun; 28(2):164-72. PubMed ID: 10825001
[TBL] [Abstract][Full Text] [Related]
29. [Molecular cloning and functional analysis of STGC3 - a novel gene on chromosome 3p21].
He XS; Xiao ZQ; Chen ZC; Zhao SP; Zhu JH; He ZM; Li YJ; Tian F; Yu YH
Ai Zheng; 2004 Oct; 23(10):1110-5. PubMed ID: 15473918
[TBL] [Abstract][Full Text] [Related]
30. Deletion of 5q in myeloid leukemia cells HL-60: an L1 element-mediated instability.
Hejlik DP; Nagarajan L
Cancer Genet Cytogenet; 2005 Jan; 156(2):97-103. PubMed ID: 15642388
[TBL] [Abstract][Full Text] [Related]
31. LAPSER1: a novel candidate tumor suppressor gene from 10q24.3.
Cabeza-Arvelaiz Y; Thompson TC; Sepulveda JL; Chinault AC
Oncogene; 2001 Oct; 20(46):6707-17. PubMed ID: 11709705
[TBL] [Abstract][Full Text] [Related]
32. SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells.
Liang H; Samanta S; Nagarajan L
Oncogene; 2005 Apr; 24(16):2625-34. PubMed ID: 15782145
[TBL] [Abstract][Full Text] [Related]
33. Defining a common region of deletion at 13q21 in human cancers.
Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
[TBL] [Abstract][Full Text] [Related]
34. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p).
Baens M; Wlodarska I; Corveleyn A; Hoornaert I; Hagemeijer A; Marynen P
Genomics; 1999 Feb; 56(1):40-50. PubMed ID: 10036184
[TBL] [Abstract][Full Text] [Related]
35. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
[TBL] [Abstract][Full Text] [Related]
36. An antisense transcript to SMAD5 expressed in fetal and tumor tissues.
Zavadil J; Svoboda P; Liang H; Kottickal LV; Nagarajan L
Biochem Biophys Res Commun; 1999 Feb; 255(3):668-72. PubMed ID: 10049768
[TBL] [Abstract][Full Text] [Related]
37. Identification of candidate liver tumor suppressor genes from human 11p11.2 by transcription mapping of microcell hybrid cell lines.
Jahn JE; Ricketts SL; Coleman WB
Int J Oncol; 2003 Jun; 22(6):1303-10. PubMed ID: 12738998
[TBL] [Abstract][Full Text] [Related]
38. Molecular mapping of chromosome 2 deletions in murine radiation-induced AML localizes a putative tumor suppressor gene to a 1.0 cM region homologous to human chromosome segment 11p11-12.
Silver A; Moody J; Dunford R; Clark D; Ganz S; Bulman R; Bouffler S; Finnon P; Meijne E; Huiskamp R; Cox R
Genes Chromosomes Cancer; 1999 Feb; 24(2):95-104. PubMed ID: 9885975
[TBL] [Abstract][Full Text] [Related]
39. Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7.
Boulay JL; Mild G; Reuter J; Lagrange M; Terracciano L; Lowy A; Laffer U; Orth B; Metzger U; Stamm B; Martinoli S; Herrmann R; Rochlitz C
Genes Chromosomes Cancer; 2001 Jul; 31(3):240-7. PubMed ID: 11391794
[TBL] [Abstract][Full Text] [Related]
40. Physical mapping of the minimal region of loss in 5q- chromosome.
Fairman J; Chumakov I; Chinault AC; Nowell PC; Nagarajan L
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7406-10. PubMed ID: 7638206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
